Global Immuno-Cell Therapy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Immuno-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Passive Immune (NK, LAK etc)
  • 1.2.3 Active Immune
• 1.3 Market by Application
  • 1.3.1 Global Immuno-Cell Therapy Market Share by Application: 2020 VS 2026
  • 1.3.2 Oncology
  • 1.3.3 Cardiovascular Disease (CVD)
  • 1.3.4 Orthopedic
  • 1.3.5 Wound Healing
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Immuno-Cell Therapy Market Perspective (2015-2026)
• 2.2 Global Immuno-Cell Therapy Growth Trends by Regions
  • 2.2.1 Immuno-Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Immuno-Cell Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Immuno-Cell Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Immuno-Cell Therapy Players by Market Size
  • 3.1.1 Global Top Immuno-Cell Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global Immuno-Cell Therapy Revenue Market Share by Players (2015-2020)
• 3.2 Global Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Immuno-Cell Therapy Revenue
• 3.4 Global Immuno-Cell Therapy Market Concentration Ratio
  • 3.4.1 Global Immuno-Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Immuno-Cell Therapy Revenue in 2019
• 3.5 Key Players Immuno-Cell Therapy Area Served
• 3.6 Key Players Immuno-Cell Therapy Product Solution and Service
• 3.7 Date of Enter into Immuno-Cell Therapy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno-Cell Therapy Breakdown Data by Type (2015-2026)

• 4.1 Global Immuno-Cell Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global Immuno-Cell Therapy Forecasted Market Size by Type (2021-2026)

5 Immuno-Cell Therapy Breakdown Data by Application (2015-2026)

• 5.1 Global Immuno-Cell Therapy Historic Market Size by Application (2015-2020)
• 5.2 Global Immuno-Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Immuno-Cell Therapy Market Size (2015-2026)
• 6.2 North America Immuno-Cell Therapy Market Size by Type (2015-2020)
• 6.3 North America Immuno-Cell Therapy Market Size by Application (2015-2020)
• 6.4 North America Immuno-Cell Therapy Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Immuno-Cell Therapy Market Size (2015-2026)
• 7.2 Europe Immuno-Cell Therapy Market Size by Type (2015-2020)
• 7.3 Europe Immuno-Cell Therapy Market Size by Application (2015-2020)
• 7.4 Europe Immuno-Cell Therapy Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Immuno-Cell Therapy Market Size (2015-2026)
• 8.2 China Immuno-Cell Therapy Market Size by Type (2015-2020)
• 8.3 China Immuno-Cell Therapy Market Size by Application (2015-2020)
• 8.4 China Immuno-Cell Therapy Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Immuno-Cell Therapy Market Size (2015-2026)
• 9.2 Japan Immuno-Cell Therapy Market Size by Type (2015-2020)
• 9.3 Japan Immuno-Cell Therapy Market Size by Application (2015-2020)
• 9.4 Japan Immuno-Cell Therapy Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Immuno-Cell Therapy Market Size (2015-2026)
• 10.2 Southeast Asia Immuno-Cell Therapy Market Size by Type (2015-2020)
• 10.3 Southeast Asia Immuno-Cell Therapy Market Size by Application (2015-2020)
• 10.4 Southeast Asia Immuno-Cell Therapy Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 MEDINET Co
  • 11.1.1 MEDINET Co Company Details
  • 11.1.2 MEDINET Co Business Overview
  • 11.1.3 MEDINET Co Immuno-Cell Therapy Introduction
  • 11.1.4 MEDINET Co Revenue in Immuno-Cell Therapy Business (2015-2020))
  • 11.1.5 MEDINET Co Recent Development
• 11.2 Erytech
  • 11.2.1 Erytech Company Details
  • 11.2.2 Erytech Business Overview
  • 11.2.3 Erytech Immuno-Cell Therapy Introduction
  • 11.2.4 Erytech Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 11.2.5 Erytech Recent Development
• 11.3 Seta Clinic Group
  • 11.3.1 Seta Clinic Group Company Details
  • 11.3.2 Seta Clinic Group Business Overview
  • 11.3.3 Seta Clinic Group Immuno-Cell Therapy Introduction
  • 11.3.4 Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 11.3.5 Seta Clinic Group Recent Development
• 11.4 Takeda
  • 11.4.1 Takeda Company Details
  • 11.4.2 Takeda Business Overview
  • 11.4.3 Takeda Immuno-Cell Therapy Introduction
  • 11.4.4 Takeda Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 11.4.5 Takeda Recent Development
• 11.5 SBI Holdings
  • 11.5.1 SBI Holdings Company Details
  • 11.5.2 SBI Holdings Business Overview
  • 11.5.3 SBI Holdings Immuno-Cell Therapy Introduction
  • 11.5.4 SBI Holdings Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 11.5.5 SBI Holdings Recent Development
• 11.6 Oxford BioTherapeutics
  • 11.6.1 Oxford BioTherapeutics Company Details
  • 11.6.2 Oxford BioTherapeutics Business Overview
  • 11.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Introduction
  • 11.6.4 Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 11.6.5 Oxford BioTherapeutics Recent Development
• 11.7 Fate Therapeutics
  • 11.7.1 Fate Therapeutics Company Details
  • 11.7.2 Fate Therapeutics Business Overview
  • 11.7.3 Fate Therapeutics Immuno-Cell Therapy Introduction
  • 11.7.4 Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 11.7.5 Fate Therapeutics Recent Development
• 11.8 Gilead Sciences
  • 11.8.1 Gilead Sciences Company Details
  • 11.8.2 Gilead Sciences Business Overview
  • 11.8.3 Gilead Sciences Immuno-Cell Therapy Introduction
  • 11.8.4 Gilead Sciences Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 11.8.5 Gilead Sciences Recent Development
• 11.9 Novartis
  • 11.9.1 Novartis Company Details
  • 11.9.2 Novartis Business Overview
  • 11.9.3 Novartis Immuno-Cell Therapy Introduction
  • 11.9.4 Novartis Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 11.9.5 Novartis Recent Development
• 11.10 Osiris
  • 11.10.1 Osiris Company Details
  • 11.10.2 Osiris Business Overview
  • 11.10.3 Osiris Immuno-Cell Therapy Introduction
  • 11.10.4 Osiris Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 11.10.5 Osiris Recent Development
• 11.11 Vericel Corporation
  • 10.11.1 Vericel Corporation Company Details
  • 10.11.2 Vericel Corporation Business Overview
  • 10.11.3 Vericel Corporation Immuno-Cell Therapy Introduction
  • 10.11.4 Vericel Corporation Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 10.11.5 Vericel Corporation Recent Development
• 11.12 Fujifilm Cellular Dynamics
  • 10.12.1 Fujifilm Cellular Dynamics Company Details
  • 10.12.2 Fujifilm Cellular Dynamics Business Overview
  • 10.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Introduction
  • 10.12.4 Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 10.12.5 Fujifilm Cellular Dynamics Recent Development
• 11.13 JCR Pharmaceuticals
  • 10.13.1 JCR Pharmaceuticals Company Details
  • 10.13.2 JCR Pharmaceuticals Business Overview
  • 10.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Introduction
  • 10.13.4 JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 10.13.5 JCR Pharmaceuticals Recent Development
• 11.14 Beike Biotechnology
  • 10.14.1 Beike Biotechnology Company Details
  • 10.14.2 Beike Biotechnology Business Overview
  • 10.14.3 Beike Biotechnology Immuno-Cell Therapy Introduction
  • 10.14.4 Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 10.14.5 Beike Biotechnology Recent Development
• 11.15 Golden Meditech
  • 10.15.1 Golden Meditech Company Details
  • 10.15.2 Golden Meditech Business Overview
  • 10.15.3 Golden Meditech Immuno-Cell Therapy Introduction
  • 10.15.4 Golden Meditech Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 10.15.5 Golden Meditech Recent Development
• 11.16 Guanhao Biotech
  • 10.16.1 Guanhao Biotech Company Details
  • 10.16.2 Guanhao Biotech Business Overview
  • 10.16.3 Guanhao Biotech Immuno-Cell Therapy Introduction
  • 10.16.4 Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 10.16.5 Guanhao Biotech Recent Development
• 11.17 Beroni Group
  • 10.17.1 Beroni Group Company Details
  • 10.17.2 Beroni Group Business Overview
  • 10.17.3 Beroni Group Immuno-Cell Therapy Introduction
  • 10.17.4 Beroni Group Revenue in Immuno-Cell Therapy Business (2015-2020)
  • 10.17.5 Beroni Group Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer